Event-Driven Stocks

Tilray Brands, Inc.

TLRYNasdaq

Healthcare · Medicinal Chemicals & Botanical Products · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 3 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$821.3M$788.9M$627.1M$628.4M$513.1M$405.3M
Operating income−$2.28B−$174.7M−$1.37B−$610.4M−$132.2M−$104.0M
Net income−$2.19B−$245.0M−$1.45B−$476.8M−$367.4M−$102.5M
Total assets$2.07B$4.22B$4.31B$5.45B$6.03B$1.74B
Total liabilities$584.8M$778.5M$977.3M$1.01B$1.56B$463.0M
Equity$1.51B$3.44B$3.32B$4.40B$4.46B$1.25B
EPS (diluted)$-2.46$-0.33$-2.35$-0.90$-1.25$-0.47
Shares out.1.10B843.0M703.3M536.4M449.2M216.2M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−277.9%
Net margin
−266.3%
Return on equity
−144.7%
Return on assets
−105.4%
Return on capital (ROCE)
−127.2%
Liabilities / assets
28.2%
Debt / equity
0.39×
Book value / share
$1.37
Revenue growth (YoY)
4.1%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-11.01distress
Accruals / assets
−100.9%clean
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
55
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 3 warning● 3 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202616.8M4.0-13.4%
Apr 30, 202619.4M1.8+35.0%
Apr 15, 202614.4M4.4+1.0%
Mar 31, 202614.3M6.0-7.5%
Mar 13, 202615.4M5.6-7.5%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)